GCP ClinPlus delivered comprehensive biostatistical services for an innovative oral targeted therapy inhibiting cancer cell proliferation, specifically developed for chronic lymphocytic leukemia ...
Record-Breaking Innovation in Chinese PharmaceuticalsChina's pharmaceutical landscape is experiencing unprecedented growth, with the National Medical Products Administration (NMPA) recently report...
Executive SummaryGCP ClinPlus successfully delivered comprehensive clinical research services that led to the groundbreaking approval of China's first stem cell therapy for acute Graft-versus-Host...
